Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

NCT04584892 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilia A

Interventions

DRUG: Turoctocog alfa

Sponsor

Novo Nordisk A/S